Goldman Sachs
SONM icon

Goldman Sachs’s DNA X Inc SONM Stock Holding History

Goldman Sachs’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-39
Closed -$58K – 6497
2021
Q1 		$58K Hold
39
– – ﹤0.01% 5923
2020
Q4 		$51K Sell
39
-36
-48% -$39.3K ﹤0.01% 5381
2020
Q3 		$105K Sell
75
-16
-18% -$25.7K ﹤0.01% 5082
2020
Q2 		$131K Buy
91
+70
+333% +$112K ﹤0.01% 4918
2020
Q1 		$26K Buy
21
+3
+17% +$14.4K ﹤0.01% 5109
2019
Q4 		$120K Sell
18
-15
-45% -$74K ﹤0.01% 5023
2019
Q3 		$172K Buy
33
+27
+450% +$414K ﹤0.01% 4856
2019
Q2 		$140K Buy
+6
New +$152K ﹤0.01% 4873

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs's SONM Position: Q2 2021 in Review

Goldman Sachs sold out of DNA X Inc (SONM) in Q2 2021, closing a stake of 39 shares — an estimated $58K sold.

Goldman Sachs first reported a position in SONM in Q2 2019 and held it in 8 quarters. The position peaked at $172K in Q3 2019. 17 funds tracked by Wall St. Rank hold SONM as of Q2 2021.

  • Goldman Sachs reported no remaining DNA X Inc position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 39 DNA X Inc shares in Q2 2021, an estimated $58K.
  • Goldman Sachs first reported a position in DNA X Inc in Q2 2019 and held it in 8 quarters.
  • Goldman Sachs's DNA X Inc position peaked at $172K in Q3 2019.
  • 17 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.